Literature DB >> 20650467

Prevalence of iron deficiency in children with Down syndrome.

Natalia E Dixon1, Blythe G Crissman, P Brian Smith, Sherri A Zimmerman, Gordon Worley, Priya S Kishnani.   

Abstract

OBJECTIVES: To determine the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) in a sample of children with Down syndrome (DS) and to evaluate the effect of macrocytosis on the diagnosis of ID/IDA in these children. STUDY
DESIGN: Children with DS ≥ 12 months of age who were followed at the Duke University Medical Center Comprehensive DS Clinic from December 2004 to March 2007 were screened for ID/IDA with a complete blood count, reticulocyte count, iron panel, and erythrocytic protoporphyrins.
RESULTS: A total of 114 children were enrolled, with a median age of 4.7 years. ID was identified in 12 subjects (10%), and IDA was identified in 3 subjects (3%). ID/IDA would not have been accurately diagnosed in 13 of 15 subjects (86%) if red blood cell (RBC) indices alone had been used for screening. Abnormal RBC indices with low transferrin saturation were 100% sensitive for ID/ IDA screening.
CONCLUSIONS: Prevalence of ID/IDA in children with DS was comparable with that in the general pediatric population. Macrocytosis had implications for screening of ID/IDA with only RBC indices. We suggest ID/IDA screening in DS children be done with a laboratory panel at least including complete blood count, reticulocyte count, transferrin saturation, and serum ferritin.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650467      PMCID: PMC2988945          DOI: 10.1016/j.jpeds.2010.06.011

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

Review 1.  Epidemiology of Down syndrome.

Authors:  Stephanie L Sherman; Emily G Allen; Lora H Bean; Sallie B Freeman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2007

2.  Peripheral blood cell counts in infants with Down's syndrome.

Authors:  S M Kivivuori; J Rajantie; M A Siimes
Journal:  Clin Genet       Date:  1996-01       Impact factor: 4.438

Review 3.  Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.

Authors:  Natalia Dixon; Priya S Kishnani; Sherri Zimmerman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

4.  Macrocytosis and leukopenia in Down's syndrome.

Authors:  K Akin
Journal:  JAMA       Date:  1988-02-12       Impact factor: 56.272

5.  National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001.

Authors:  Mark A Canfield; Margaret A Honein; Nataliya Yuskiv; Jian Xing; Cara T Mai; Julianne S Collins; Owen Devine; Joann Petrini; Tunu A Ramadhani; Charlotte A Hobbs; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

6.  Anemia is a poor predictor of iron deficiency among toddlers in the United States: for heme the bell tolls.

Authors:  Keith C White
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

7.  Prevalence of iron deficiency in the United States.

Authors:  A C Looker; P R Dallman; M D Carroll; E W Gunter; C L Johnson
Journal:  JAMA       Date:  1997-03-26       Impact factor: 56.272

8.  Iron deficiency in children with attention-deficit/hyperactivity disorder.

Authors:  Eric Konofal; Michel Lecendreux; Isabelle Arnulf; Marie-Christine Mouren
Journal:  Arch Pediatr Adolesc Med       Date:  2004-12

9.  Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children.

Authors:  Eric Konofal; Samuele Cortese; Martine Marchand; Marie-Christine Mouren; Isabelle Arnulf; Michel Lecendreux
Journal:  Sleep Med       Date:  2007-07-20       Impact factor: 3.492

Review 10.  An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function.

Authors:  Joyce C McCann; Bruce N Ames
Journal:  Am J Clin Nutr       Date:  2007-04       Impact factor: 7.045

View more
  4 in total

1.  Anemia in children with down syndrome.

Authors:  Ariel Tenenbaum; Sarah Malkiel; Isaiah D Wexler; Floris Levy-Khademi; Shoshana Revel-Vilk; Polina Stepensky
Journal:  Int J Pediatr       Date:  2011-09-14

Review 2.  The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.

Authors:  Bruce X Wong; James A Duce
Journal:  Front Pharmacol       Date:  2014-04-21       Impact factor: 5.810

3.  Association of the Single Nucleotide Polymorphisms in RUNX1, DYRK1A, and KCNJ15 with Blood Related Traits in Pigs.

Authors:  Jae-Bong Lee; Chae-Kyoung Yoo; Hee-Bok Park; In-Cheol Cho; Hyun-Tae Lim
Journal:  Asian-Australas J Anim Sci       Date:  2016-08-04       Impact factor: 2.509

Review 4.  Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.

Authors:  Romina María Uranga; Gabriela Alejandra Salvador
Journal:  Oxid Med Cell Longev       Date:  2018-01-31       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.